开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向：哮喘;巨噬细胞 经验分享：来积攒人品。3月21日提交，3月22日with editor ，4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200114, encodeId=d48a2200114a5, content=4.4号投稿，4.5号with editor 4.18号还是with editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e884788237, createdName=mxy268133mxy, createdTime=Wed Apr 24 12:19:18 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向：免疫 经验分享：2024.03.08 submitted to journal 2024.03.08 with editor 投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化，杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬，jornal of autoimmunity投稿对摘要和全文没有字数要求吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下，为什么投稿第二步，attach files 总过不去，也上传文件了，就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-04-08 14706479m35(暂无昵称) 来自山东省

偏重的研究方向：哮喘;巨噬细胞
经验分享：来积攒人品。3月21日提交，3月22日with editor ，4月6日decision in process,目前还是decision in process

78 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向：哮喘;巨噬细胞 经验分享：来积攒人品。3月21日提交，3月22日with editor ，4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200114, encodeId=d48a2200114a5, content=4.4号投稿，4.5号with editor 4.18号还是with editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e884788237, createdName=mxy268133mxy, createdTime=Wed Apr 24 12:19:18 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向：免疫 经验分享：2024.03.08 submitted to journal 2024.03.08 with editor 投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化，杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬，jornal of autoimmunity投稿对摘要和全文没有字数要求吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下，为什么投稿第二步，attach files 总过不去，也上传文件了，就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-04-24 mxy268133mxy 来自浙江省

4.4号投稿，4.5号with editor 4.18号还是with editor

81 0

[GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向：哮喘;巨噬细胞 经验分享：来积攒人品。3月21日提交，3月22日with editor ，4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200114, encodeId=d48a2200114a5, content=4.4号投稿，4.5号with editor 4.18号还是with editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e884788237, createdName=mxy268133mxy, createdTime=Wed Apr 24 12:19:18 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向：免疫 经验分享：2024.03.08 submitted to journal 2024.03.08 with editor 投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化，杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬，jornal of autoimmunity投稿对摘要和全文没有字数要求吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下，为什么投稿第二步，attach files 总过不去，也上传文件了，就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-05-05 Mis 吴

有没有人可以分享一下投稿进程？谢谢

167 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向：哮喘;巨噬细胞 经验分享：来积攒人品。3月21日提交，3月22日with editor ，4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200114, encodeId=d48a2200114a5, content=4.4号投稿，4.5号with editor 4.18号还是with editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e884788237, createdName=mxy268133mxy, createdTime=Wed Apr 24 12:19:18 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向：免疫 经验分享：2024.03.08 submitted to journal 2024.03.08 with editor 投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化，杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬，jornal of autoimmunity投稿对摘要和全文没有字数要求吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下，为什么投稿第二步，attach files 总过不去，也上传文件了，就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-03-11 1487e742m42(暂无昵称) 来自内蒙古

偏重的研究方向：免疫
经验分享：2024.03.08 submitted to journal
2024.03.08 with editor
投稿时忘记上传WB 的原始图片PDF了。。。

86 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向：哮喘;巨噬细胞 经验分享：来积攒人品。3月21日提交，3月22日with editor ，4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200114, encodeId=d48a2200114a5, content=4.4号投稿，4.5号with editor 4.18号还是with editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e884788237, createdName=mxy268133mxy, createdTime=Wed Apr 24 12:19:18 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向：免疫 经验分享：2024.03.08 submitted to journal 2024.03.08 with editor 投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化，杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬，jornal of autoimmunity投稿对摘要和全文没有字数要求吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下，为什么投稿第二步，attach files 总过不去，也上传文件了，就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-03-19 ms3236964720522021 来自陕西省

提交到期刊近20天没有变化，杂志首页却介绍首个决定5天。

99 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向：哮喘;巨噬细胞 经验分享：来积攒人品。3月21日提交，3月22日with editor ，4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200114, encodeId=d48a2200114a5, content=4.4号投稿，4.5号with editor 4.18号还是with editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e884788237, createdName=mxy268133mxy, createdTime=Wed Apr 24 12:19:18 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向：免疫 经验分享：2024.03.08 submitted to journal 2024.03.08 with editor 投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化，杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬，jornal of autoimmunity投稿对摘要和全文没有字数要求吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下，为什么投稿第二步，attach files 总过不去，也上传文件了，就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-01-01 ms3000000202046104 来自吉林省

请问各位大佬，jornal of autoimmunity投稿对摘要和全文没有字数要求吗？

92 0

[GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向：哮喘;巨噬细胞 经验分享：来积攒人品。3月21日提交，3月22日with editor ，4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200114, encodeId=d48a2200114a5, content=4.4号投稿，4.5号with editor 4.18号还是with editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e884788237, createdName=mxy268133mxy, createdTime=Wed Apr 24 12:19:18 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向：免疫 经验分享：2024.03.08 submitted to journal 2024.03.08 with editor 投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化，杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬，jornal of autoimmunity投稿对摘要和全文没有字数要求吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下，为什么投稿第二步，attach files 总过不去，也上传文件了，就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-12-12 ms7000001739408141 来自北京

有哪位大神可以告知一下，为什么投稿第二步，attach files 总过不去，也上传文件了，就是不行

88 0

[GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向：哮喘;巨噬细胞 经验分享：来积攒人品。3月21日提交，3月22日with editor ，4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200114, encodeId=d48a2200114a5, content=4.4号投稿，4.5号with editor 4.18号还是with editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e884788237, createdName=mxy268133mxy, createdTime=Wed Apr 24 12:19:18 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向：免疫 经验分享：2024.03.08 submitted to journal 2024.03.08 with editor 投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化，杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬，jornal of autoimmunity投稿对摘要和全文没有字数要求吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下，为什么投稿第二步，attach files 总过不去，也上传文件了，就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2019-04-17 138200c9a8m

综述要约稿吗？

356 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向：哮喘;巨噬细胞 经验分享：来积攒人品。3月21日提交，3月22日with editor ，4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200114, encodeId=d48a2200114a5, content=4.4号投稿，4.5号with editor 4.18号还是with editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e884788237, createdName=mxy268133mxy, createdTime=Wed Apr 24 12:19:18 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向：免疫 经验分享：2024.03.08 submitted to journal 2024.03.08 with editor 投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化，杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬，jornal of autoimmunity投稿对摘要和全文没有字数要求吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下，为什么投稿第二步，attach files 总过不去，也上传文件了，就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

上传文章时应该上传word还是pdf？

176 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向：哮喘;巨噬细胞 经验分享：来积攒人品。3月21日提交，3月22日with editor ，4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200114, encodeId=d48a2200114a5, content=4.4号投稿，4.5号with editor 4.18号还是with editor , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e884788237, createdName=mxy268133mxy, createdTime=Wed Apr 24 12:19:18 CST 2024, time=2024-04-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向：免疫 经验分享：2024.03.08 submitted to journal 2024.03.08 with editor 投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化，杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬，jornal of autoimmunity投稿对摘要和全文没有字数要求吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下，为什么投稿第二步，attach files 总过不去，也上传文件了，就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 rayms

什么是推荐reviewer/专家/同行？

173 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务